Opus Capital Group, LLC Abbott Laboratories Transaction History

Opus Capital Group, LLC

$800 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $100 - $112	1 Added 0.03%	3,387 $369,000
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $3,486 - $4,104	-36 Reduced 1.05%	3,386 $343,000
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $13,783 - $16,170	-145 Reduced 4.07%	3,422 $376,000
Q2 2022 Jul 29, 2022	SELL	$102.07 - $123.37 $2,551 - $3,084	-25 Reduced 0.7%	3,567 $388,000
Q1 2022 Apr 25, 2022	BUY	$114.02 - $139.04 $2,850 - $3,476	25 Added 0.7%	3,592 $425,000
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $120,159 - $132,931	-1,030 Reduced 22.41%	3,567 $421,000
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $46,441 - $54,668	-439 Reduced 8.72%	4,597 $533,000
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $100,132 - $117,971	-920 Reduced 15.45%	5,036 $604,000
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $1,260 - $1,373	12 Added 0.2%	5,956 $652,000
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $84,308 - $102,386	-920 Reduced 13.4%	5,944 $647,000
Q2 2020 Jul 31, 2020	SELL	$76.57 - $98.0 $6,891 - $8,820	-90 Reduced 1.29%	6,864 $628,000
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $169,488 - $247,838	-2,698 Reduced 27.95%	6,954 $549,000
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $6,359 - $7,079	-81 Reduced 0.83%	9,652 $838,000
Q3 2019 Nov 04, 2019	BUY	$81.84 - $88.74 $2,046 - $2,218	25 Added 0.26%	9,733 $814,000
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $107,862 - $125,800	1,480 Added 17.99%	9,708 $816,000
Q1 2019 Apr 30, 2019	SELL	$66.22 - $80.06 $139,657 - $168,846	-2,109 Reduced 20.4%	8,228 $657,000
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $13,112 - $14,854	200 Added 1.97%	10,337 $748,000
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $78,748 - $95,001	-1,295 Reduced 11.33%	10,137 $743,000
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $549,421 - $613,212	11,432	11,432 $610,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.

Account